U.S. Joins Whistleblower Suit Against PharMerica
The complaint filed in Wisconsin federal court alleges PharMerica “routinely” dispensed Schedule II narcotics like oxycodone and fentanyl at the request of nursing home staff and without a doctor’s written approval, violating the Controlled Substances Act.
The Louisville, Ky.-based company also breached the FCA by...
To view the full article, register now.